Simple, Sensitive, and Scalable: QuantideX Suite of Assays for Targeted MRD Monitoring of Leukemic Fusions

The QuantideX qPCR BCR-ABL IS (IVD) and Minor (RUO) Kits, as well as the upcoming qPCR PML-RARA Kit (RUO)**, provide highly sensitive and scalable methods for detection and quantification of MRD involving these fusions, allowing for molecular laboratories big and small to implement such tests using widely available qPCR equipment. In this corporate workshop, we will review the key features and attributes of these assays and will describe key performance data illustrating why QuantideX is the portfolio of choice for highly sensitive detection of leukemic fusions.